Balaji Gandhi, the Chief Financial Officer of $PHR, sold 3,829 shares of the company on 03-25-2026 for an estimated $43,127. We received data on the trade from a recent SEC filing. This was a sale of approximately 2.5% of their shares of this class of stock. Following this trade, they now own 146,740 shares of this class of $PHR stock.
$PHR Insider Trading Activity
$PHR insiders have traded $PHR stock on the open market 36 times in the past 6 months. Of those trades, 3 have been purchases and 33 have been sales.
Here’s a breakdown of recent trading of $PHR stock by insiders over the last 6 months:
- FIRE CAPITAL SE PALE has made 3 purchases buying 1,602,505 shares for an estimated $18,304,679 and 0 sales.
- CHAIM INDIG (Chief Executive Officer) has made 0 purchases and 4 sales selling 24,236 shares for an estimated $420,972.
- ALLISON C HOFFMAN (General Counsel & Secretary) has made 0 purchases and 5 sales selling 19,103 shares for an estimated $297,129.
- BALAJI GANDHI (Chief Financial Officer) has made 0 purchases and 5 sales selling 18,385 shares for an estimated $291,761.
- EVAN ROBERTS (President, Provider Solutions) has made 0 purchases and 4 sales selling 16,283 shares for an estimated $281,823.
- DAVID LINETSKY (President, Network Solutions) has made 0 purchases and 6 sales selling 16,147 shares for an estimated $279,931.
- AMY BETH VANDUYN (SVP, Human Resources) has made 0 purchases and 4 sales selling 6,130 shares for an estimated $105,811.
- YVONNE HUI (Principal Accounting Officer) has made 0 purchases and 5 sales selling 1,844 shares for an estimated $32,481.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PHR Hedge Fund Activity
We have seen 132 institutional investors add shares of $PHR stock to their portfolio, and 138 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 6,477,456 shares (-98.6%) from their portfolio in Q4 2025, for an estimated $109,598,555
- FMR LLC removed 3,556,113 shares (-90.7%) from their portfolio in Q4 2025, for an estimated $60,169,431
- GREENHOUSE FUNDS LLLP removed 1,410,567 shares (-36.3%) from their portfolio in Q4 2025, for an estimated $23,866,793
- LOOMIS SAYLES & CO L P removed 1,170,559 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $19,805,858
- CHAMPLAIN INVESTMENT PARTNERS, LLC removed 1,068,884 shares (-39.9%) from their portfolio in Q4 2025, for an estimated $18,085,517
- GRANAHAN INVESTMENT MANAGEMENT, LLC added 1,018,987 shares (+73.8%) to their portfolio in Q4 2025, for an estimated $17,241,260
- PROSIGHT MANAGEMENT, LP added 977,152 shares (+inf%) to their portfolio in Q4 2025, for an estimated $16,533,411
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$PHR Revenue
$PHR had revenues of $120.3M in Q3 2026. This is an increase of 12.67% from the same period in the prior year.
You can track PHR financials on Quiver Quantitative's PHR stock page.
$PHR Congressional Stock Trading
Members of Congress have traded $PHR stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $PHR stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 10/09.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$PHR Analyst Ratings
Wall Street analysts have issued reports on $PHR in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 12/10/2025
- Citigroup issued a "Buy" rating on 12/09/2025
- Needham issued a "Buy" rating on 12/09/2025
- Canaccord Genuity issued a "Buy" rating on 12/09/2025
- JP Morgan issued a "Overweight" rating on 12/09/2025
- DA Davidson issued a "Buy" rating on 12/02/2025
- BMO Capital issued a "Outperform" rating on 11/13/2025
To track analyst ratings and price targets for $PHR, check out Quiver Quantitative's $PHR forecast page.
$PHR Price Targets
Multiple analysts have issued price targets for $PHR recently. We have seen 11 analysts offer price targets for $PHR in the last 6 months, with a median target of $25.0.
Here are some recent targets:
- Stan Berenshteyn from Wells Fargo set a target price of $25.0 on 03/26/2026
- Steven Valiquette from Mizuho set a target price of $19.0 on 03/24/2026
- Alexei Gogolev from JP Morgan set a target price of $24.0 on 02/20/2026
- Clark Wright from DA Davidson set a target price of $30.0 on 01/23/2026
- Daniel Grosslight from Citigroup set a target price of $25.0 on 01/09/2026
- Glen Santangelo from Barclays set a target price of $24.0 on 12/16/2025
- Joseph Vruwink from Baird set a target price of $25.0 on 12/10/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
